Progress in Acute Myeloid Leukemia: Adapting Treatment to Individual Patients
  • Program Overview
    Progress in Acute Myeloid Leukemia: Adapting Treatment to Individual Patients
    In this online educational program, CCO’s expert faculty explore optimal care for patients with AML, including predictive/prognostic factors to consider in selecting treatment for AML, management of newly diagnosed AML, treatment of relapsed/refractory disease and novel agents that may affect care in the near future.
  • Featured content
    Watch this on-demand Webcast from the CCO AML satellite symposium at ASH 2017, featuring expert faculty Jeffrey E. Lancet, MD; Gail J. Roboz, MD; B. Douglas Smith, MD; and Roland B. Walter, MD, PhD, MS, as they discuss the most clinically relevant advances in treatment strategies for patients with AML.
  • Featured content
    In this downloadable slideset, Jeffrey E. Lancet, MD, explores current strategies for treating patients with newly diagnosed acute myeloid leukemia based on patient medical history and cytogenetic and molecular markers.
    Date Posted: 12/13/2017
  • Featured content
    In this downloadable slideset, Gail J. Roboz, MD, explores optimal treatment approaches for patients with relapsed/refractory acute myeloid leukemia.
    Date Posted: 12/13/2017
  • Featured content
    Download this guide for a quick overview of current approaches in the use of molecular analysis to individualize treatment strategies in patients with acute myeloid leukemia.
    Date Posted: 12/7/2017
  • 1
  • 2
  • 3
  • 4
  • 5

Latest Content

10 of 10 Shown
10 of 10 Shown
Show 0 More
Loading...